Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP762650.RAhMI11wfZ5yytXpmxChhNqvbY5sSfhauWY_asUQ7oerE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP762650.RAhMI11wfZ5yytXpmxChhNqvbY5sSfhauWY_asUQ7oerE130_assertion type Assertion NP762650.RAhMI11wfZ5yytXpmxChhNqvbY5sSfhauWY_asUQ7oerE130_head.
- NP762650.RAhMI11wfZ5yytXpmxChhNqvbY5sSfhauWY_asUQ7oerE130_assertion description "[ARX mutation testing should be undertaken in children aged less than 1 year with Ohtahara syndrome and a movement disorder, and in infants with unexplained neurodegeneration, progressive white matter loss, and cortical atrophy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP762650.RAhMI11wfZ5yytXpmxChhNqvbY5sSfhauWY_asUQ7oerE130_provenance.
- NP762650.RAhMI11wfZ5yytXpmxChhNqvbY5sSfhauWY_asUQ7oerE130_assertion evidence source_evidence_literature NP762650.RAhMI11wfZ5yytXpmxChhNqvbY5sSfhauWY_asUQ7oerE130_provenance.
- NP762650.RAhMI11wfZ5yytXpmxChhNqvbY5sSfhauWY_asUQ7oerE130_assertion SIO_000772 19747203 NP762650.RAhMI11wfZ5yytXpmxChhNqvbY5sSfhauWY_asUQ7oerE130_provenance.
- NP762650.RAhMI11wfZ5yytXpmxChhNqvbY5sSfhauWY_asUQ7oerE130_assertion wasDerivedFrom befree-2016 NP762650.RAhMI11wfZ5yytXpmxChhNqvbY5sSfhauWY_asUQ7oerE130_provenance.
- NP762650.RAhMI11wfZ5yytXpmxChhNqvbY5sSfhauWY_asUQ7oerE130_assertion wasGeneratedBy ECO_0000203 NP762650.RAhMI11wfZ5yytXpmxChhNqvbY5sSfhauWY_asUQ7oerE130_provenance.